Risk of hematoma following needle electromyography of the paraspinal muscles.
Jon T Gertken, Christopher H Hunt, Nataly I Montes Chinea, Jonathan M Morris, Eric J Sorenson and Andrea J Boon Muscle Nerve 44(3):439-40 (2011) PMID 21996804
The purpose of this study was to establish the incidence of MRI-detectable hematomas following paraspinal EMG. We provide a retrospective review of patients who underwent paraspinal EMG and subsequent concordant level spine MRI. A total of 370 charts (431 MRIs) met the inclusion criteria. No paraspinal hematomas were observed. These results should further the development of evidence-based guidelines for patients who have greater-than-normal bleeding risk and support the notion that paraspinal EMG is a relatively safe procedure. Muscle Nerve 44: 439-440, 2011. Copyright © 2011 Wiley Periodicals, Inc.
Hematoma risk after needle EMG
Andrea J. Boon MD1,2,*, Jon T. Gertken MD1, James C. Watson MD2, Ruple S. Laughlin MD2, Jeffrey A. Strommen MD1, Michelle L. Mauermann MD2, Eric J. Sorenson MD2
Abstract
Introduction:
Although needle electromyography (EMG) appears to be a relatively safe procedure based primarily on clinical experience, no evidence-based guidelines exist for EMG procedures in patients taking anticoagulant or antiplatelet medications.
Objectives:
To determine if there is an increased risk of hematoma formation after EMG of potentially high risk muscles in patients taking anticoagulant or antiplatelet agents.
Methods:
After undergoing routine EMG, if any of 7 predetermined high risk muscles were tested, study subjects then underwent ultrasound to evaluate for hematoma formation.
Results:
Patients were divided into 3 groups based on medication (warfarin; aspirin/clopidogrel; no blood-thinning medication), with at least 100 muscles examined per group. Two small, subclinical hematomas were seen on ultrasound; there was no difference in hematoma risk between groups (p=0.43)
Conclusions:
This study suggests that hematoma formation from standard needle EMG is rare even in high risk muscles, which have been avoided historically in anticoagulated patients.